Similar articles

• Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.

  Manousaridis I, Loeser C, Goerdt S, Hassel JC. Manousaridis I, et al. Acta Dermatovenerol Alp Pannonica Adriat. 2010 Dec;19(4):15-9. Acta Dermatovenerol Alp Pannonica Adriat. 2010. PMID: 21390475
• [Scleromyxedema with neurological symptoms: successful treatment with immunoglobulins].

  Manríquez J, Berroeta-Mauriziano D, Andino-Navarrete R, Vera-Kellet C. Manríquez J, et al. Med Clin (Barc). 2015 Jan 6;144(1):47-8. doi: 10.1016/j.medcli.2014.02.008. Epub 2014 Mar 18. Med Clin (Barc). 2015. PMID: 24656121 Spanish. No abstract available.
• Scleromyxedema with an interstitial granulomatous-like pattern: a rare histologic variant mimicking granuloma annulare.

  Rongioletti F, Cozzani E, Parodi A. Rongioletti F, et al. J Cutan Pathol. 2010 Oct;37(10):1084-7. doi: 10.1111/j.1600-0560.2009.01386.x. Epub 2009 Jul 22. J Cutan Pathol. 2010. PMID: 19638067
• Scleromyxedema.

  Hummers LK. Hummers LK. Curr Opin Rheumatol. 2014 Nov;26(6):658-62. doi: 10.1097/BOR.0000000000000118. Curr Opin Rheumatol. 2014. PMID: 25215418 Review.
• Unveiling the enigma: a case-based review of scleromyxedema.

  Rogowska J, Styrzyński F, Makowska J, Brzezińska O. Rogowska J, et al. Rheumatol Int. 2025 Jan 8;45(1):22. doi: 10.1007/s00296-024-05775-2. Rheumatol Int. 2025. PMID: 39777523 Review.